top of page

The Role of Immunotherapy in the Management of Late Stage NSCLC and the Role of the Multidisciplinary Tumor Board

CHEST
9/16/20, 5:00 PM
America/Chicago UTC -5

Description

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Eric Edell

Describe the latest evidence and best practice in the use of immunotherapy in treating NSCLC, Describe effective multidisciplinary case management of patients with NSCLC who may benefit from immunotherapy

Inglês

Description

Speakers

Narjust Duma, Julian Molina

Speakers
Link to Event
Banner
Registro
bottom of page